Case Managers Streamline Transfer Process

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

Prescreening patients before transfer from one cancer facility to another gives the receiving hospital an opportunity to prepare needed services for that patient, "thereby maximizing resources and providing quality care more efficiently," Kathy Rogala-Scherer, RN, Department of Case Management, Roswell Park Cancer Institute (RPCI), said at the 31st Annual Congress of the Oncology Nursing Society (abstract 35).

BOSTON—Prescreening patients before transfer from one cancer facility to another gives the receiving hospital an opportunity to prepare needed services for that patient, "thereby maximizing resources and providing quality care more efficiently," Kathy Rogala-Scherer, RN, Department of Case Management, Roswell Park Cancer Institute (RPCI), said at the 31st Annual Congress of the Oncology Nursing Society (abstract 35).

Key information required to streamline the admitting process includes insurance, demographics, history, and special needs status, and pertinent clinical data supporting the cancer diagnosis. Oncology nurse case managers evaluate the information and review it with the accepting oncologist and with the intensivist if a critical care bed is indicated.

"With prescreening, we can better manage the needs of the patients who come to the Institute," Ms. Rogala-Scherer said. "For example, we can adjust if a patient requires a private room because of being MRSA [methicillin-resistant Staphylococcus aureus] positive or if they have physical limitations, such as being morbidly obese and unable to fit into a standard hospital bed." In this initial review of cases in 2005, RPCI accepted 274 transfers; only 10 patients were declined for transfer.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The FDA approval of tarlatamab in SCLC has received much press attention, according to Daniel R. Carrizosa, MD, MS.
These new guidelines aim to alleviate some of the problems caused by patients with peritoneal metastases being diagnosed with the disease in late stages.
A combined cohort composed of patients from the TROPION-Lung01 and TROPION-Lung-05 trials showed a survival advantage with dato-DXd vs docetaxel.
The National ICE-T Conference may inspire future collaboration between community and academic oncologists in the management of different cancers.
4 experts in this video
2 experts are featured in this series.
4 experts in this video
5 experts are featured in this series
Related Content